People Professor Ellie Barnes
Principal Investigator, Institute for Emerging Infections
Professor of Hepatology and Experimental Medicine
One of the aims of my programme is to develop a prophylactic and therapeutic hepatitis C virus vaccine (HCV). HCV is currently a global epidemic infecting 170 million people worldwide and a significant issue in the United Kingdom, where 0.4 % of the population are infected. Hope for a vaccine for HCV lies in the fact that after primary infection spontaneous viral eradication occurs in a significant minority of patients.